Oncopeptides AB (publ)
ONPPF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 33.8% | 16.5% | 4.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100.6% | 92.7% | 91.8% | 88.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -451% | -840.6% | -720% | -898.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -457.3% | -841.5% | -708% | -898.1% |
| EPS Diluted | -0.28 | -0.39 | -0.39 | -0.48 |
| % Growth | 28.2% | 0% | 18.7% | – |
| Operating Cash Flow | – | -$0 | -$0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | $0 |